Pages that link to "Q51301868"

The following pages link to Berberine inhibits dyslipidemia in C57BL/6 mice with lipopolysaccharide induced inflammation (Q51301868):

Displaying 21 items.

• Berberis vulgaris and its constituent berberine as antidotes and protective agents against natural or chemical toxicities (Q33819605) (← links)
• Sanmiao formula inhibits chondrocyte apoptosis and cartilage matrix degradation in a rat model of osteoarthritis (Q34119782) (← links)
• PCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells (Q34433146) (← links)
• Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9). (Q34458693) (← links)
• PCSK9 is a critical regulator of the innate immune response and septic shock outcome. (Q35125516) (← links)
• Berberine Reduces Neurotoxicity Related to Nonalcoholic Steatohepatitis in Rats (Q36241424) (← links)
• Cancer prevention and therapy through the modulation of the tumor microenvironment (Q37058267) (← links)
• Berberine protects against esophageal mucosal damage in reflux esophagitis by suppressing proinflammatory cytokines (Q37207028) (← links)
• A comprehensive overview of hepatoprotective natural compounds: mechanism of action and clinical perspectives (Q38588143) (← links)
• The Proprotein Convertases in Hypercholesterolemia and Cardiovascular Diseases: Emphasis on Proprotein Convertase Subtilisin/Kexin 9. (Q39030028) (← links)
• PCSK9 at the crossroad of cholesterol metabolism and immune function during infections (Q39072663) (← links)
• Effect of anti-hyperlipidemia drugs on the alpha-tocopherol concentration and their potential for murine malaria infection (Q41006475) (← links)
• ANGPTL3 is part of the machinery causing dyslipidemia majorily via LPL inhibition in mastitis mice (Q47380241) (← links)
• GW4064 attenuates lipopolysaccharide‑induced hepatic inflammation and apoptosis through inhibition of the Toll‑like receptor 4‑mediated p38 mitogen‑activated protein kinase signaling pathway in mice (Q50068098) (← links)
• Update on the Benefits and Mechanisms of Action of the Bioactive Vegetal Alkaloid Berberine on Lipid Metabolism and Homeostasis (Q57177401) (← links)
• Berberine: Botanical Occurrence, Traditional Uses, Extraction Methods, and Relevance in Cardiovascular, Metabolic, Hepatic, and Renal Disorders (Q58728400) (← links)
• Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics (Q64084960) (← links)
• Influence of specific endothelin-1 receptor blockers on hemodynamic parameters and antioxidant status of plasma in LPS-induced endotoxemia (Q86109950) (← links)
• The gut microbiome and metabolic syndrome (Q90409959) (← links)
• Electrospun cellulose acetate/gelatin nanofibrous wound dressing containing berberine for diabetic foot ulcer healing: in vitro and in vivo studies (Q95320002) (← links)
• Nutrition, Bioenergetics, and Metabolic Syndrome (Q99549278) (← links)